RTOG 0534: A Phase III Trial of Short Term Androgen Depriviation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPORT) in Prostate Cancer With a Rising PSA After Radical Prostatectomy
CTO - 4896
Cancer Genitourinary/ Prostate
Principal Investigator: Eleanor M Walker, MD
This randomized phase III trial is studying prostate radiation therapy to see how well it works compared with short-term androgen deprivation therapy given together with pelvic lymph node radiation therapy with or without prostate radiation therapy in treating patients with a rising PSA after surgery for prostate cancer.
- Males at least 18 years of age
- Any type of radical prostatectomy will be permitted, including retropubic, perineal, laparoscopic, or robotically assisted